Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Innovative Pharmaceutical Biotech ( (HK:0399) ).
Innovative Pharmaceutical Biotech Limited announced significant changes in its board of directors effective April 7, 2025. The company has accepted the resignations of Mr. Li Jiehong as executive director and Ms. Jiang Nian as non-executive director, both stepping down to focus on personal business engagements. The board expressed gratitude for their contributions. In their place, Dr. Long Fan and Dr. Wu Ming have been appointed as executive directors, while Dr. Xia Tingkang, Tim, joins as an independent non-executive director. Additionally, Mr. Tang Rong has been appointed to the remuneration committee. These changes are expected to bring fresh perspectives and expertise to the company’s leadership, potentially impacting its strategic direction and stakeholder relations.
More about Innovative Pharmaceutical Biotech
Innovative Pharmaceutical Biotech Limited operates in the pharmaceutical and biotechnology industry, focusing on the development and commercialization of innovative medical solutions.
YTD Price Performance: -25.48%
Average Trading Volume: 864,611
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$282.4M
Find detailed analytics on 0399 stock on TipRanks’ Stock Analysis page.